Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis is a chronic lung condition that causes scarring of the lungs, making it harder to breathe. It affects the lung tissue, particularly the areas responsible for oxygen exchange. Over time, the scarring worsens, leading to shortness of breath, a persistent dry cough, and fatigue. The exact cause is unknown, which is why it is called idiopathic. This disease mainly impacts the ability to get enough oxygen into the bloodstream, affecting overall health and daily activities.

Idiopathic Pulmonary Fibrosis (IPF) is a progressive interstitial lung disease characterized by fibrosis and remodeling of the lung parenchyma without a known cause. The core pathology involves excessive deposition of extracellular matrix and collagen, leading to distortion of alveolar architecture and impaired gas exchange. It primarily affects older adults and is associated with a poor prognosis due to progressive respiratory failure. The disease is distinguished by a usual interstitial pneumonia (UIP) pattern on histology or high-resolution CT. The pathogenesis involves repeated alveolar epithelial injury and aberrant wound healing. IPF is clinically significant because it leads to chronic hypoxemia, respiratory insufficiency, and increased mortality.